Table 2.
Proportion of Venous Thromboembolism among Patients Eligible and Those Not Eligible for Post-Discharge Low Molecular Weight Heparin (n = 1,043)
| Variable | Pre-intervention | Post-intervention | p Value | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Eligible | |||||
| Post-discharge | |||||
| VTE | 20 | 2.5 | 0 | 0.0 | <0.01 |
| DVT | 15 | 1.9 | 0 | 0.0 | 0.03 |
| PE | 5 | 0.6 | 0 | 0.0 | 0.60 |
| Inpatient | |||||
| VTE | 6 | 0.7 | 4 | 1.7 | 0.25 |
| DVT | 6 | 0.7 | 2 | 0.8 | >0.99 |
| PE | 0 | 0.0 | 2 | 0.8 | 0.05 |
| Not eligible* | |||||
| Post-discharge | 12 | 0.5 | 3 | 0.6 | >0.99 |
| VTE | |||||
| DVT | 10 | 0.4 | 3 | 0.6 | 0.72 |
| PE | 5 | 0.2 | 0 | 0.0 | 0.59 |
| Inpatient | |||||
| VTE | 41 | 0.2 | 1 | 0.2 | >0.99 |
| DVT | 3 | 0.1 | 1 | 0.2 | 0.57 |
| PE | 1 | 0.04 | 0 | 0.0 | >0.99 |
*
Patients who underwent any surgery other than abdominal surgery for malignancy or inflammatory bowel disease; n 2,834. DVT, deep vein thrombosis; PE, pulmonary embolism; VTE, venous thromboembolism.